Polyphase wireless power transfer system achieves 270-kilowatt charge, s...
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
Four research teams from the Department of Energy’s Oak Ridge National Laboratory and their technologies have received 2020 R&D 100 Awards.
Experts at the Department of Energy’s Oak Ridge National Laboratory are now offering short-term technical and scientific assistance to entities working to combat the coronavirus through the COVID-19 Technical Assistance Program, an initiative of DOE’s Office of Technology Transitions.
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.
Scientists at Oak Ridge National Laboratory have demonstrated a direct relationship between climate warming and carbon loss in a peatland ecosystem.
Scientists at ORNL used neutron scattering and supercomputing to better understand how an organic solvent and water work together to break down plant biomass, creating a pathway to significantly improve the production of renewable
Researchers at the Department of Energy’s Oak Ridge National Laboratory and the University of Tennessee, Knoxville, are advancing gas membrane materials to expand practical technology options for reducing industrial carbon emissions.
Scientists from the Department of Energy’s Oak Ridge National Laboratory and a dozen other international research institutions have produced the most elaborate set of projections to date that illustrates possible futures for major monsoon regions.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
Oak Ridge National Laboratory has launched a program designed to accelerate deployment of innovations that may help fight the COVID-19 pandemic. The COVID-19 Rapid Access Licensing Program will allow companies to license these select technologies at no cost for one year.